ADAPT Act
The Antibiotic Development to Advance Patient Treatment (ADAPT) Act was introduced in the U.S. Congress on December 12, 2013 by Representative Phil Gingrey of Georgia and fifty-two cosponsors. Responding to the lack of financial incentives for drug manufacturers to innovate new antibiotics and antifungals and the regulatory barriers to their doing so, it proposed an expedited pathway for testing drugs intended for diseases for which no cure yet existed. After it died in committee, a similar version of the Act was re-introduced by Representative John Shimkus of Illinois and his cosponsor Representative Gene Green of Texas. Though this Act likewise failed to make it out of committee, several of its provisions were codified in the 21st Century Cures Act, which was signed into law on December
Wikipage redirect
Link from a Wikipage to another Wikipage
primaryTopic
ADAPT Act
The Antibiotic Development to Advance Patient Treatment (ADAPT) Act was introduced in the U.S. Congress on December 12, 2013 by Representative Phil Gingrey of Georgia and fifty-two cosponsors. Responding to the lack of financial incentives for drug manufacturers to innovate new antibiotics and antifungals and the regulatory barriers to their doing so, it proposed an expedited pathway for testing drugs intended for diseases for which no cure yet existed. After it died in committee, a similar version of the Act was re-introduced by Representative John Shimkus of Illinois and his cosponsor Representative Gene Green of Texas. Though this Act likewise failed to make it out of committee, several of its provisions were codified in the 21st Century Cures Act, which was signed into law on December
has abstract
The Antibiotic Development to ...... icrobial susceptibility tests.
@en
Wikipage page ID
46,434,889
page length (characters) of wiki page
Wikipage revision ID
985,966,011
Link from a Wikipage to another Wikipage
wikiPageUsesTemplate
comment
The Antibiotic Development to ...... s signed into law on December
@en
label
ADAPT Act
@en